The trial involved 81 children between the ages of 2 and 18 that suffered up to 18 seizures a month resulting from Dravet ...

A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.

Ovid Therapeutics (OVID) shares jumped over 40% premarket as the biopharmaceutical company reported favorable safety and tolerability results for the 7 mg dose of its OV329 epilepsy drug, while ...

Robert Butler is raising awareness of the condition, as he says "misconceptions can be dangerous".

Executive dysfunction in drug-resistant epilepsy is common and linked to greater ASM load/number of ASMs and increased ...

Seizure control may take time—often a year or more—but most patients achieve it, bringing new hope for life with epilepsy. For millions of people living with ...